Junpei Ohtsuka
Tsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Trajectories and determinants of respiratory syncytial virus prefusion F-specific IgG in older adults.
Journal: BMC infectious diseases
Published: December 16, 2025
Temporal trends in RSV-specific antibody seroprevalence among hosptalized children during the COVID-19 pandemic in Japan: a retrospective cross-sectional study.
Journal: BMC infectious diseases
Published: November 12, 2025
Next Generation RNA/Protein-Carrying Vector With Pleiotropic Activity.
Journal: Reviews in medical virology
Published: February 09, 2024
Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.
Journal: iScience
Published: February 24, 2021
A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis.
Journal: Nature communications
Published: June 06, 2019
Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.
Journal: Virology
Published: August 20, 2018
The Hemagglutinin-Neuraminidase (HN) Head Domain and the Fusion (F) Protein Stalk Domain of the Parainfluenza Viruses Affect the Specificity of the HN-F Interaction.
Journal: Frontiers in microbiology
Published: November 15, 2017
The Fusion Protein Specificity of the Parainfluenza Virus Hemagglutinin-Neuraminidase Protein Is Not Solely Defined by the Primary Structure of Its Stalk Domain.
Journal: Journal of virology
Published: June 04, 2015
Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector.
Journal: Gene therapy
Published: August 28, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026